Natera (NTRA) Net Shares Issued and Repurchased (2014 - 2025)
Natera's (NTRA) quarterly Net Shares Issued and Repurchased came in at $2000.0 in Q4 2025, down 98.08% quarter-over-quarter from $104000.0 in Q1 2025.
Analysis
Natera (NTRA) Net Shares Issued and Repurchased (2014 - 2025) Analysis & Trends
Natera (NTRA) has reported Net Shares Issued and Repurchased for 12 consecutive years, with $2000.0 the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Net Shares Issued and Repurchased changed N/A year-over-year to $2000.0; the trailing twelve-month figure through Dec 2025 stood at $2000.0 (changed N/A YoY), and the FY2025 full-year result was $2000.0, changed N/A from the prior year.
- Net Shares Issued and Repurchased eased to $2000.0 in Q4 2025 per NTRA's latest filing, from $104000.0 in the prior quarter.
- Across five years, Net Shares Issued and Repurchased topped out at $934000.0 in Q4 2023 and bottomed at $2000.0 in Q4 2025.
- Historically, Net Shares Issued and Repurchased has averaged $287600.0 across 5 years, with a median of $156500.0 in 2021.
- The sharpest annual moves came in 2023 and 2024: Net Shares Issued and Repurchased soared 188.18% in 2023, then slumped 70.35% in 2024.
- Over 5 years, Net Shares Issued and Repurchased stood at $291000.0 in 2021, then soared by 144.33% to $711000.0 in 2022, then jumped by 31.36% to $934000.0 in 2023, then plunged by 89.94% to $94000.0 in 2024, then plunged by 97.87% to $2000.0 in 2025.
- According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $2000.0, $104000.0, and $94000.0 for Q4 2025, Q1 2025, and Q1 2024 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn | - |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn | - |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn | - |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn | - |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn | - |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn | - |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn | - |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn | - |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn | - |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 2,000.00 |
| Mar 31, 2025 | 104,000.00 |
| Mar 31, 2024 | 94,000.00 |
| Dec 31, 2023 | 934,000.00 |
| Mar 31, 2023 | 317,000.00 |
| Dec 31, 2022 | 711,000.00 |
| Mar 31, 2022 | 110,000.00 |
| Dec 31, 2021 | 291,000.00 |
| Jun 30, 2021 | 163,000.00 |
| Mar 31, 2021 | 150,000.00 |
| Dec 31, 2020 | 436,000.00 |
| Sep 30, 2020 | 10,000.00 |
| Mar 31, 2020 | 88,000.00 |
| Dec 31, 2019 | 1.84 Mn |
| Mar 31, 2019 | 200,000.00 |
| Dec 31, 2018 | 2.32 Mn |
| Mar 31, 2018 | 1.15 Mn |
| Dec 31, 2017 | 135,746.00 |
| Mar 31, 2017 | 287,000.00 |
| Dec 31, 2016 | 141,046.00 |